Mylan Loses Bid To Stall Trial Over Neurim's Melatonin Patent - Law360

A judge has refused generic-drug maker Mylan's request to stay Neurim's patent infringement litigation to wait for a European Patent Office ruling on the validity of the Israeli pharmaceutical company's melatonin patent, saying on Friday that the...